Evidence map›Paper›PMID 31672333›Full record

ArticleVaccine2020

Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries.

Kayoko Shioda, Lucia Helena de Oliveira, Jennifer Sanwogou, Gloria Rey-Benito, Diana Nuñez Azzad, Roxana Elizabeth Castillo, María Liz Gamarra Ramírez, Marta Raquel Von Horoch, Daniel M Weinberger, Virginia E Pitzer

Abstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kayoko ShiodaDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut 06520-8034, USA. Electronic address: kayoko.shioda@yale.edu.
Lucia Helena de OliveiraImmunization Unit, Pan American Health Organization, Washington DC 20037, USA.
Jennifer SanwogouImmunization Unit, Pan American Health Organization, Washington DC 20037, USA.
Gloria Rey-BenitoImmunization Unit, Pan American Health Organization, Washington DC 20037, USA.
Diana Nuñez AzzadJefa Unidad de Vigilancia de la Salud, Secretaria de Salud- Honduras, Avenida Miguel Cervantes, Tegucigalpa, Honduras.
Roxana Elizabeth CastilloLaboratorio Nacional, Tegucigalpa, Honduras.
María Liz Gamarra RamírezLaboratori Central de Salud Publica de Paraguay, Asuncion, Paraguay.
Marta Raquel Von HorochDirección General de Vigilancia de la Salud, Ministerio de Salud Pública y Bienestar Social, Asunción, Paraguay.
Daniel M WeinbergerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut 06520-8034, USA.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut 06520-8034, USA.

Funding

Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countriesR01AI112970 · NIAID · YALE UNIVERSITY · PI PITZER, VIRGINIA E · 2015 to 2024
$4.1M
NIAID NIH HHS R01 AI112970
6 · The paper itself

Abstract

backgroundPassive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics.

methodsWe used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression.

resultsAll countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10-22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3-7.2%) in Honduras to 21.4% (16.8-25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries.

conclusionsThe combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact.

Indexed as

Child, PreschoolDiarrheaHospitalizationHumansImmunization ProgramsIncidenceLatin AmericaRotavirus InfectionsRotavirus VaccinesSeasonsSentinel SurveillanceVaccinationRotavirus VaccinesHarmonic regressionImperfect surveillance dataLatin AmericaRotavirusSentinel surveillanceVaccine evaluation

Identifiers

PMID31672333
PMCPMC9236179

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.